Arjun Masurkar, MD, PhD: New Treatment on the Horizon for Alzheimer Disease
Arjun Masurkar, MD, PhD, previews some of the new medications that could help treat Alzheimer disease, while reviewing some of the advancements of the last decade.
Margaret Nachtigall, MD: Managing Menopause
Patient demographics influence difference symptoms, progression, and benefits of care.
Purvi Parikh, MD: Pediatric Asthma Care with Biologics
How to weigh the 5 agents from the drug class, which have each shown differing benefit in younger patients.
USPSTF: Inconclusive Evidence for Lead Screening in Asymptomatic Children
A task force found insufficient evidence on the benefits and harms of screening for lead in asymptomatic children and pregnant persons.
Short Stays in Skilled Nursing Facilities Linked to High Readmission Rates
Investigators found readmission risk was 4 times greater in patients with stays of 2 days or less.
Chirag Barbhaiya, MD: The Average Afib Patient
As Americans population ages, yet becomes more health conscious, has the average patient suffering from Afib changed in recent years?
Jeffrey Berger, MD: When to use GLP1 Agonists or SGLT2 Inhibitors
How and when do you decide whether to prescribe a patient GLP1 agonists or SGLT2 inhibitors?
Charla Fischer, MD: Discussing the Future of Orthopedics
How has technology changed the way orthopedic specialists practice and what is driving advances such as minimally invasive spine surgery?
Jeffrey Berger, MD: Future of Heart Health
What are some of the future risks, in terms of cardiovascular health, facing the average patient?
Jeffrey Berger, MD: Impact of Updated Aspirin Guidelines
Insight regarding the recent change to aspirin guidelines and what it means for patients from platelet specialist Jeffrey Berger, MD.
Chirag Barbhaiya, MD: How Ablation Success Rates are Misleading
Barbhaiya talks about what he considers to be misleading success rates for Afib ablation being published in studies.
Chirag Barbhaiya, MD: Apple Heart Study Reaction
Discussing the implications and future of wearable technology after the release of the Apple Heart Study.
Charla Fischer, MD: Orthopedic Patients Going Forward
What sort of problems will orthopedic surgeons face in the future and how has the average patient changed in recent years?
Chirag Barbhaiya, MD: Updated Afib Guidelines
MD Magazine sat down with Chirag Barbhaiya, MD, of NYU Langone Health, to discuss the updated guidelines for treating a patient with Afib.
Transcranial Stimulation at Home Reduces Fatigue in Multiple Sclerosis
A sham-controlled trial demonstrated that a novel at-home administration of transcranial stimulation reduced fatigue in multiple sclerosis.
James Underberg, MD: Statin Intolerance, Drug Costs in Cardiovascular Care
The seemingly complicated maneuvers of getting patient’s cholesterol better can be resolved with common sense. What’s best for the patient?
James Underberg, MD: The Alirocumab-Evolocumab Race
Since the PCSK9 inhibitors were approved for cholesterol management by the FDA in 2015, they have been frequently compared.